Neuronetics (STIM) Gross Margin (2017 - 2026)
Neuronetics' (STIM) quarterly Gross Margin came in at 46.89% in Q1 2026, down 233.0% year-on-year from 35.25% in Q1 2025, and down 9.75% on a QoQ basis from 51.95% in Q4 2025.
Neuronetics (STIM) Gross Margin (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has 10 years of Gross Margin data on file, last reported at 46.89% in Q1 2026.
- On a quarterly basis, Gross Margin fell 233.0% year-over-year to 46.89% in Q1 2026; TTM through Mar 2026 was 47.96%, a 1555.0% decrease from a year earlier, with the FY2025 full-year figure at 48.48%, down 2384.0% from the prior year.
- Gross Margin for Q1 2026 stood at 46.89%, down from 51.95% in the prior quarter.
- Over the last five years, Gross Margin for STIM reached as high as 78.36% in Q3 2022 and fell as low as 45.87% in Q3 2025.
- Historically, Gross Margin has averaged 66.22% across 5 years, with a median of 73.33% in 2023.
- Across the five-year window, Gross Margin soared 978 bps in 2024 and slumped 2969 bps in 2025, its largest moves.
- Year by year, Gross Margin stood at 75.88% in 2022, then grew by 2 bps to 77.64% in 2023, then decreased by 15 bps to 66.21% in 2024, then decreased by 22 bps to 51.95% in 2025, then fell by 10 bps to 46.89% in 2026.
- Per Business Quant data, the three most recent Gross Margin figures were 46.89% in Q1 2026, 51.95% in Q4 2025, and 45.87% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuronetics | 130.83 Mn | 128.62 Mn | 16.15 Mn | 46.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.89% |
| Dec 31, 2025 | 51.95% |
| Sep 30, 2025 | 45.87% |
| Jun 30, 2025 | 46.60% |
| Mar 31, 2025 | 49.22% |
| Dec 31, 2024 | 66.21% |
| Sep 30, 2024 | 75.56% |
| Jun 30, 2024 | 74.04% |
| Mar 31, 2024 | 75.14% |
| Dec 31, 2023 | 77.64% |
| Sep 30, 2023 | 65.78% |
| Jun 30, 2023 | 72.54% |
| Mar 31, 2023 | 73.33% |
| Dec 31, 2022 | 75.88% |
| Sep 30, 2022 | 78.36% |
| Jun 30, 2022 | 75.26% |
| Mar 31, 2022 | 75.42% |
| Dec 31, 2021 | 76.45% |
| Sep 30, 2021 | 77.22% |
| Jun 30, 2021 | 80.64% |